Ondine Biomedical Inc. (LON:OBI – Get Free Report)’s stock price hit a new 52-week low on Wednesday . The company traded as low as GBX 5.11 ($0.06) and last traded at GBX 5.19 ($0.07), with a volume of 165537 shares trading hands. The stock had previously closed at GBX 5.38 ($0.07).
Ondine Biomedical Stock Down 3.4 %
The company has a debt-to-equity ratio of 24.39, a current ratio of 2.34 and a quick ratio of 8.26. The firm has a 50 day simple moving average of GBX 8.48 and a 200-day simple moving average of GBX 9.30. The stock has a market capitalization of £11.77 million, a price-to-earnings ratio of -86.50 and a beta of -0.15.
About Ondine Biomedical
Ondine Biomedical Inc, a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens.
Further Reading
- Five stocks we like better than Ondine Biomedical
- Following Congress Stock Trades
- AMD is Down 35%. Now is the Time to Buy the Dip
- 3 Monster Growth Stocks to Buy Now
- Amazon Stands Tall: New Highs Are in Sight
- What is a SEC Filing?
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
